RELMADA THERAPEUTICS INC

Relmada Therapeutics: Nasdaq‑listed New York drug company driving innovative pain‑management solutions with a $570M market cap and dynamic stock performance.

Relmada Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing innovative pain management solutions, with a potential to revolutionize the field and drive change in the healthcare industry.